7CPY image
Deposition Date 2020-08-08
Release Date 2021-01-13
Last Version Date 2024-05-29
Entry Detail
PDB ID:
7CPY
Title:
Lovastatin nonaketide synthase with LovC
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.60 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Lovastatin nonaketide synthase, polyketide synthase component
Gene (Uniprot):lovB
Mutations:G1884Q, Q1885A
Chain IDs:C (auth: A), D (auth: B)
Chain Length:3046
Number of Molecules:2
Biological Source:Aspergillus terreus
Polymer Type:polypeptide(L)
Molecule:Lovastatin nonaketide synthase, enoyl reductase component lovC
Gene (Uniprot):lovC
Chain IDs:A (auth: C), B (auth: D)
Chain Length:371
Number of Molecules:2
Biological Source:Aspergillus terreus
Ligand Molecules
Primary Citation
Structural basis for the biosynthesis of lovastatin.
Nat Commun 12 867 867 (2021)
PMID: 33558520 DOI: 10.1038/s41467-021-21174-8

Abstact

Statins are effective cholesterol-lowering drugs. Lovastatin, one of the precursors of statins, is formed from dihydromonacolin L (DML), which is synthesized by lovastatin nonaketide synthase (LovB), with the assistance of a separate trans-acting enoyl reductase (LovC). A full DML synthesis comprises 8 polyketide synthetic cycles with about 35 steps. The assembling of the LovB-LovC complex, and the structural basis for the iterative and yet permutative functions of the megasynthase have remained a mystery. Here, we present the cryo-EM structures of the LovB-LovC complex at 3.60 Å and the core LovB at 2.91 Å resolution. The domain organization of LovB is an X-shaped face-to-face dimer containing eight connected domains. The binding of LovC laterally to the malonyl-acetyl transferase domain allows the completion of a L-shaped catalytic chamber consisting of six active domains. This architecture and the structural details of the megasynthase provide the basis for the processing of the intermediates by the individual catalytic domains. The detailed architectural model provides structural insights that may enable the re-engineering of the megasynthase for the generation of new statins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures